🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT03861507
Recruiting Not applicable

Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound

NCT03861507 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2020-03-04
Last updated
2025-03-28

Condition(s) studied

Prostate Cancer

Investigational drug(s) / intervention(s)

Prostate Brachytherapy

Prostate Brachytherapy: High dose - rate (HDR) brachytherapy

Study summary

This study involves patients who are scheduled for standard care brachytherapy of focal tumours within the prostate, which is normally performed under standard 2-dimensional (2D) ultrasound guidance. The purpose of this study is the acquire power Doppler ultrasound while using a simple oscillator in physical contact with the end of a brachytherapy needle. The vibrations along the needle should be visible in the power Doppler ultrasound, helping to visualize the needle position within the anatomy.

Eligibility

Sex
MALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Male, aged 18 years or older * Willing to provide written consent * Pathologically confirmed prostate cancer on previous biopsy * Suitable for and consenting to high-dose-rate brachytherapy for treatment as standard of care. Exclusion Criteria: * • Previous radiotherapy to the prostate

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Victoria Hospital London Ontario Recruiting

More Western University, Canada trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03861507 on ClinicalTrials.gov ↗ ← All trials in Canada